您当前的位置:检测资讯 > 其他

日本关于部分修订放射性药品最低要求

嘉峪检测网        2015-10-22 23:36

通报号: G/TBT/N/JPN/499
ICS号: 11
发布日期: 2015-09-16
截至日期: 2015-09-24
通报成员: 日本
目标和理由: 保护人类安全和健康
内容概述: 部分修订放射性药品最低要求,增加了最近批准的放射性药品标准。
正文: 
世界贸易组织
G/TBT/N/JPN/499
2015-09-16
15-4742
 
技术性贸易壁垒
原文:英语
 
通 报


                   以下通报根据TBT协定第10.6条分发

1.
通报成员: 日本
如可能,列出涉及的地方政府名称 ( 3.2条和7.2 条):
2.
负责机构:厚生劳动省(MHLW)
3.
通报依据条款:2.9.2
4.
覆盖的产品: 药品。 HS: 30
HS编码:30   ICS编码:11
5.
通报标题: 部分修订放射性药品最低要求

语言:英语 页数:1 链接网址:
 
6.
内容简述:部分修订放射性药品最低要求,增加了最近批准的放射性药品标准。
7.
目标与理由:为了公众健康和卫生规定了药品必须特别注意的生产加工、特性、质量、存储标准及其它标准(放射性药品)。
8.
相关文件: 关于药品、医疗器械、再生细胞治疗产品、基因治疗产品和化妆品质量保证、功效和安全的法案。批准时本修订公布在官方公报上。
9.
拟批准日期:放射性药品批准之日
拟生效日期:放射性药品批准之日
10.
意见反馈截止日期: 2015/09/24
11.
文本可从以下机构得到:

正文(英): 

NOTIFICATION

The following notification is being circulated in accordance with Article 10.6

 

1.

Notifying Member: Japan

If applicable, name of local government involved (Article 3.2 and 7.2):

2.

Agency responsible: Ministry of Health, Labour and Welfare

Name and address (including telephone and fax numbers, email and website addresses, if available) of agency or authority designated to handle comments regarding the notification shall be indicated if different from above:

3.

Notified under Article 2.9.2 [X], 2.10.1 [ ], 5.6.2 [ ], 5.7.1 [ ], other:

4.

Products covered (HS or CCCN where applicable, otherwise national tariff heading. ICS numbers may be provided in addition, where applicable): Pharmaceutical products (HS: 30)

5.

Title, number of pages and language(s) of the notified document: Partial amendment to the Minimum Requirements for Radiopharmaceuticals (1 pages, in English)

6.

Description of content: The minimum requirements for radiopharmaceuticals are to be partially amended to add the standards for a radiopharmaceutical to be newly approved.

7.

Objective and rationale, including the nature of urgent problems where applicable: To establish the standard for manufacturing process, properties, quality, storage and others of drugs to which special attention must be paid for the attainment of public health and sanitation (radiopharmaceuticals).

8.

Relevant documents: The act on securing quality, efficacy and safety of pharmaceuticals, medical devices, regenerative and cellular therapy products, gene therapy products, and cosmetics. This amendment will be published in "KAMPO" (Official Gazette) when adopted.

9.

Proposed date of adoption: The same day as the approval of the radiopharmaceutical

Proposed date of entry into force: The same day as the approval of the radiopharmaceutical

10.

Final date for comments: 24 September 2015

11.

Texts available from: National enquiry point [X] or address, telephone and fax numbers and email and website addresses, if available, of other body:

Japan Enquiry Point

International Trade Division

Economic Affairs Bureau

Ministry of Foreign Affairs

Fax: (+81 3) 5501 8343

E-mail: enquiry@mofa.go.jp

https://members.wto.org/crnattachments/2015/TBT/JPN/15_3631_00_e.pdf

 

本网维权及免责声明:

      ①凡本网所有原始/编译文章及图片、图表的版权均属江苏省技术性贸易措施信息平台(www.tbtguide.com)所有,如要转载,需注明"信息来源:江苏省技术性贸易措施信息平台"或"信息来源:tbtguide"。违反上述规定者,本网将保留追究其侵权责任的权利。

      ②凡本网注明"信息来源:XXX(非tbtguide)"的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责。

      联系E-mail:js_wto@163.com

分享到:

来源:未知

相关新闻: